The committee noted that the name change from TURis to PLASMA was not accompanied by any change to the technology. Therefore, they concluded that the previous evidence of equivalent clinical outcomes ...

En bloc resection of bladder tumor has recently emerged as an alternative to TURBT aiming to improve surgical quality and pathological assessment.

Transurethral resection (TUR) followed by adjuvant intravesical therapy is the standard treatment for T1 bladder cancer, but a growing body of evidence suggests that this might be insufficient to ...

1.1 The evidence supports the case for adopting the PLASMA system for bipolar transurethral resection and haemostasis of the prostate. Clinical outcomes are comparable with monopolar transurethral ...

Salvage Treatment With Paclitaxel, Ifosfamide, and Cisplatin Plus High-Dose Carboplatin, Etoposide, and Thiotepa Followed by Autologous Stem-Cell Rescue in Patients With Relapsed or Refractory Germ ...

Effectiveness and safety of first-line atezolizumab in locally advanced or metastatic urothelial cancer: The IMFLAME study. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers ...

Please provide your email address to receive an email when new articles are posted on . Transurethral resection of bladder tumor plus systemic therapy induced clinical complete response among a large ...

Following a transurethral resection (TUR) prostatectomy for a benign enlargement, the patient complains of the lack of ejaculation and little emission, although he has a good erection. He does not ...

Even though transurethral resection of the prostate (TURP) is the standard surgical treatment for benign prostatic hyperplasia (BPH), there is a high rate of postoperative retrograde ejaculation. To ...

The collaboration includes the initial validation and deployment of Ibex Prostate within HNL Lab Medicine’s LDT workflow.